Developed in conjunction with

June, 2014
SOM Biotech will attend next BIO International Convention through its Canadian partner Willow Tree Capital Group...
April, 2014
SOM Biotech and The Vall d'Hebron Institute of...

July, 2013

SOM has licensed to the biotech  ARGON Pharma  a new product with potential properties for the treatment of multiforme glioblastoma. The compound was discovered by SOM as SOM0777.